Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy

NCT06667622 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chemoradiotherapy

Interventions

DRUG: sodium glycididazole

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences